Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 27 Nov 2006 |
| Novozymes, changes management/auditors | 20 Nov 2006 |
| Novozymes, Group financial statement for the first nine months of 2006 | 25 Oct 2006 |
| Novozymes, Trading by insiders in Novozymes A/S B shares | 25 Aug 2006 |
| Novozymes, Acquisition of own shares | 23 Aug 2006 |